The influence of Amazonian and Atlantic flora in the vegetation of cerrado sensu stricto

A contribuição das floras Atlântica e Amazônica foi analisada em doze localidades no bioma do cerrado. Um total de 290 espécies de arbustos e árvores foram registradas nas localidades de cerrado. Deste total 41,1% ocorreram apenas no cerrado, sendo provavelmente endêmicas e 58,9% ocorreram nas florestas Atlântica e Amazônica. Para as espécies não endêmicas, a contribuição da floresta Atlântica foi maior (44,8%) do que a da floresta Amazônica (1,4%), com as 12,7% de espécies restantes ocorrendo nos dois biomas florestais. A proporção de espécies com centro de distribuição na floresta Atlântica e Amazônica mostraram um pequeno decréscimo em direção ao centro do bioma do cerrado. Para o primeiro, a distância explicou apenas 30% da variação na proporção de espécies, por um modelo polinomial ajustado aos dados e, para o último, um modelo linear explicou 78% da variação. A proporção de espécies com centro de distribuição na floresta Atlântica mostrou um pequeno aumento com a altitude, mas um modelo polinomial explicou apenas 18% dessa variação. Inversamente, ocorreu um decréscimo linear na proporção de espécies com a altitude para aquelas com centro de distribuição na floresta Amazônica; o modelo explicou 31% da variação. As diferenças na contribuição das floras da floresta Atlântica e Amazônica para a fisionomia de cerrado é discutida com relação às mudanças climáticas durante o Quaternário e diferenças na tolerância entre espécies às queimadas e baixas temperaturas no bioma do Cerrado.The contribution of Amazonian and Atlantic floras was analyzed in twelve localities in the cerrado biome. A total of 290 tree and shrub species were recorded in those localities. Of these, 41.1% occurred only in cerrado and are probably endemic, and 58.9% also occurred in Atlantic and/or Amazonian forest. For non-endemic species the contribution of Atlantic forest was greater (44.8%) than Amazonian ones (1.4%), with the remaining 12.7% species found in both forest biomes. The proportions of species with centers of distribution in Atlantic and Amazonian forest showed a slight decrease toward the center of cerrado biome. For the former, the distance explained only 30% of variation in proportions by a polynomial model fit to the data, and for the latter a significant linear model explained 78% of variations. The flora of Amazon forest and Atlantic forest showed a segregation with altitude. The proportions of species with centers of distribution in the Atlantic forest showed a slight increase with altitude, but a polynomial model explained only 18% of this variation. Inversely, there was a linear relationship between the proportions of species with centers of distribution in Amazonian forest and altitude that explained 31% of variation. The differences in contribution patterns of the Atlantic and Amazonian forest flora to the cerrado physiognomy is discussed with respect to climatic changes during the Quaternary and to differences in plant species tolerance to fire and low temperature in the cerrado biome

Data sources for drug utilization research in Latin American countries—A cross-national study: DASDUR-LATAM study

Purpose: Drug utilization research (DUR) contributes to inform policymaking and to strengthen health systems. The availability of data sources is the first step for conducting DUR. However, documents that systematize these data sources in Latin American (LatAm) countries are not known. We compiled the potential data sources for DUR in the LatAm region. Methods: A network of DUR experts from nine LatAm countries was assembled and experts conducted: (i) a website search of the government, academic, and private health institutions; (ii) screening of eligible data sources, and (iii) liaising with national experts in pharmacoepidemiology (via an online survey). The data sources were characterized by accessibility, geographic granularity, setting, sector of the data, sources and type of the data. Descriptive analyses were performed. Results: We identified 125 data sources for DUR in nine LatAm countries. Thirty-eight (30%) of them were publicly and conveniently available; 89 (71%) were accessible with limitations, and 18 (14%) were not accessible or lacked clear rules for data access. From the 125 data sources, 76 (61%) were from the public sector only; 46 (37%) were from pharmacy records; 43 (34%) came from ambulatory settings and; 85 (68%) gave access to individual patient-level data. Conclusions: Although multiple sources for DUR are available in LatAm countries, the accessibility is a major challenge. The procedures for accessing DUR data should be transparent, feasible, affordable, and protocol-driven. This inventory could permit a comparison of drug utilization between countries identifying potential medication-related problems that need further exploration.Fil: Lopes, Luciane C.. University Of Sorocaba; BrasilFil: Salas, Daiana Maribel. University of Pennsylvania; Estados UnidosFil: Osorio de Castro, Claudia Garcia Serpa. Fundación Oswaldo Cruz; BrasilFil: Freitas Leal, Lisiane. McGill University; CanadáFil: Doubova, Svetlana V.. Mexican Institute of Social Security; MéxicoFil: Cañás, Martín. Universidad Nacional Arturo Jauretche; Argentina. Federación Médica de la Provincia de Buenos Aires; ArgentinaFil: Dreser, Anahi. Instituto Nacional de Salud Pública; MéxicoFil: Acosta, Angela. Universidad ICESI; ColombiaFil: Oliveira Baldoni, Andre. Federal University of São João Del-Rei; BrasilFil: de Cássia Bergamaschi, Cristiane. University of Sorocaba; BrasilFil: Marques Mota, Daniel. Brazilian Health Regulatory Agency; BrasilFil: Gómez Galicia, Diana L.. Universidad Autónoma del Estado de Morelos; MéxicoFil: Sepúlveda Viveros, Dino. Universidad de Chile; ChileFil: Narvaez Delgado, Edgard. No especifíca;Fil: da Costa Lima, Elisangela. Universidade Federal do Rio de Janeiro; BrasilFil: Chandia, Felipe Vera. Pontificia Universidad Católica de Chile; ChileFil: Ferre, Felipe. Universidade Federal de Minas Gerais; BrasilFil: Marin, Gustavo Horacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata; ArgentinaFil: Olmos, Ismael. State Health Services Administration; UruguayFil: Zimmermann, Ivan R.. Universidade do Brasília; BrasilFil: Fulone, Izabela. University of Sorocaba; BrasilFil: Roldán Saelzer, Juan. Instituto de Salud Pública; ChileFil: Sánchez Salgado, Juan Carlos. No especifíca;Fil: Castro Pastrana, Lucila I.. Universidad de Las Américas de Puebla; MéxicoFil: de Souza, Luiz Jupiter Carneiro. Fundación Oswaldo Cruz; BrasilFil: Machado Beltrán, Manuel. Universidad Nacional de Colombia; ColombiaFil: Tolentino Silva, Marcus. University of Sorocaba; BrasilFil: Mena, María Belén. Universidad Central del Ecuador; EcuadorFil: de França Fonteles, Marta Maria. Universidade Federal do Ceara; BrasilFil: Urtasun, Martín Alejandro. Universidad Nacional Arturo Jauretche; Argentina. Federación Médica de la Provincia de Buenos Aires; Argentin

Photography-based taxonomy is inadequate, unnecessary, and potentially harmful for biological sciences

The question whether taxonomic descriptions naming new animal species without type specimen(s) deposited in collections should be accepted for publication by scientific journals and allowed by the Code has already been discussed in Zootaxa (Dubois & Nemésio 2007; Donegan 2008, 2009; Nemésio 2009a–b; Dubois 2009; Gentile & Snell 2009; Minelli 2009; Cianferoni & Bartolozzi 2016; Amorim et al. 2016). This question was again raised in a letter supported by 35 signatories published in the journal Nature (Pape et al. 2016) on 15 September 2016. On 25 September 2016, the following rebuttal (strictly limited to 300 words as per the editorial rules of Nature) was submitted to Nature, which on 18 October 2016 refused to publish it. As we think this problem is a very important one for zoological taxonomy, this text is published here exactly as submitted to Nature, followed by the list of the 493 taxonomists and collection-based researchers who signed it in the short time span from 20 September to 6 October 2016

Mitochondrial physiology

As the knowledge base and importance of mitochondrial physiology to evolution, health and disease expands, the necessity for harmonizing the terminology concerning mitochondrial respiratory states and rates has become increasingly apparent. The chemiosmotic theory establishes the mechanism of energy transformation and coupling in oxidative phosphorylation. The unifying concept of the protonmotive force provides the framework for developing a consistent theoretical foundation of mitochondrial physiology and bioenergetics. We follow the latest SI guidelines and those of the International Union of Pure and Applied Chemistry (IUPAC) on terminology in physical chemistry, extended by considerations of open systems and thermodynamics of irreversible processes. The concept-driven constructive terminology incorporates the meaning of each quantity and aligns concepts and symbols with the nomenclature of classical bioenergetics. We endeavour to provide a balanced view of mitochondrial respiratory control and a critical discussion on reporting data of mitochondrial respiration in terms of metabolic flows and fluxes. Uniform standards for evaluation of respiratory states and rates will ultimately contribute to reproducibility between laboratories and thus support the development of data repositories of mitochondrial respiratory function in species, tissues, and cells. Clarity of concept and consistency of nomenclature facilitate effective transdisciplinary communication, education, and ultimately further discovery